9. 7. 2026
Estimated operating results in the first half of 2026
2 min. read
The AGM of Krka, tovarna zdravil, d. d., Novo mesto (Slovenia), assembled at Hotel Otočec today for its 32nd regular meeting. The President of the Management Board and CEO, Jože Colarič, presented the Krka Group’s key business results for 2025 and an estimate of the selected operating results for the first half of 2026. He stated: ‘We performed very successfully in the first half of the year. Estimated revenue reached €1,119.3 million, up 7%. We increased revenue in five sales regions and most of our markets. Generally, operating results for the first half of the year have been the best since incorporation. Operating profit (EBIT) increased by 20% to €309.2 million. Net profit increased as well, exceeding €260 million. EBITDA margin stood at 31.9%. We expanded our product portfolio with six prescription pharmaceuticals and one product for companion animals. We continued all key investment projects in Slovenia and abroad, aiming to increase manufacturing capacity and strengthen our vertically integrated business model.’
The Supervisory Board is scheduled to discuss unaudited operating results of Krka and the Krka Group for the first half of 2026 at its regular meeting on 22 July, and we plan to publish a press release on the following day. The performance estimate for the first half of 2026 indicates we will achieve our annual plan targets by the end of the year.
Krka Group estimated operating results for H1 2026
| € million | Estimate Jan–Jun 2026 | Index | |
| Revenue | 1,119.3 | 1,048.5 | 107 |
| – Of that revenue from contracts with customers (products and services) | 1,113.8 | 1,045.8 | 107 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | 357.5 | 303.3 | 118 |
| Operating profit (EBIT) | 309.2 | 257.0 | 120 |
| Net profit | 260.2 | 246.7 | 105 |
| Ratios | |||
| EBITDA margin | 31.9% | 28.9% | |
| EBIT margin | 27.6% | 24.5% | |
| Net profit margin (ROS) | 23.2% | 23.5% |
Sales
Estimated product and service sales by region for H1 2026
Region Slovenia,6.1
Region South-East Europe,14.3
Region East Europe,36.4
Region Central Europe,23.1
Region West Europe,16.3
Region Overseas Markets,3.8
RELATED CONTENT
Press release: Estimated Operating Results for the First Half of 2026 (9.7.2026)